First Financial Corp Bristol Myers Squibb CO Transaction History

First Financial Corp

$208 Million
Q3 2024

A detailed history of First Financial Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First Financial Corp holds 9,753 shares of BMY stock, worth $540,803. This represents 0.24% of its overall portfolio holdings.

Number of Shares

9,753

Previous 9,753 -0.0%

Holding current value

$540,803

Previous $405,000 24.44%

% of portfolio

0.24%

Previous 0.21%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$40.25 - $52.99 $50,433 - $66,396	-1,253 Reduced 11.38%	9,753 $405,000
Q1 2024 Apr 12, 2024	SELL	$47.98 - $54.4 $281,402 - $319,056	-5,865 Reduced 34.76%	11,006 $596,000
Q4 2023 Jan 16, 2024	SELL	$48.48 - $57.85 $48 - $57	-1 Reduced 0.01%	16,871 $865,000
Q3 2023 Oct 11, 2023	BUY	$57.89 - $64.73 $336,340 - $376,081	5,810 Added 52.52%	16,872 $979,000
Q2 2023 Jul 14, 2023	SELL	$63.71 - $70.74 $1,401 - $1,556	-22 Reduced 0.2%	11,062 $707,000
Q3 2022 Oct 20, 2022	BUY	$0.13 - $76.84 $5 - $3,380	44 Added 0.4%	11,084 $788,000
Q2 2022 Jul 15, 2022	SELL	$72.62 - $79.98 $29,048 - $31,992	-400 Reduced 3.5%	11,040 $851,000
Q1 2022 Apr 14, 2022	SELL	$61.48 - $73.72 $6,148 - $7,372	-100 Reduced 0.87%	11,440 $835,000
Q4 2021 Jan 14, 2022	BUY	$53.63 - $62.52 $2,842 - $3,313	53 Added 0.46%	11,540 $719,000
Q3 2021 Oct 18, 2021	BUY	$59.17 - $69.31 $5,917 - $6,931	100 Added 0.88%	11,487 $679,000
Q2 2021 Jul 15, 2021	BUY	$61.91 - $67.42 $27,673 - $30,136	447 Added 4.09%	11,387 $761,000
Q1 2021 Apr 15, 2021	SELL	$59.34 - $66.74 $17,802 - $20,022	-300 Reduced 2.67%	10,940 $691,000
Q2 2020 Jul 15, 2020	SELL	$54.82 - $64.09 $19,187 - $22,431	-350 Reduced 3.02%	11,240 $660,000
Q1 2020 Apr 15, 2020	BUY	$46.4 - $67.43 $6,496 - $9,440	140 Added 1.22%	11,590 $646,000
Q4 2019 Jan 15, 2020	SELL	$49.21 - $64.19 $13,581 - $17,716	-276 Reduced 2.35%	11,450 $735,000
Q3 2019 Oct 15, 2019	BUY	$42.77 - $50.71 $1,112 - $1,318	26 Added 0.22%	11,726 $595,000
Q2 2019 Jul 15, 2019	SELL	$44.62 - $49.34 $31,234 - $34,538	-700 Reduced 5.65%	11,700 $530,000
Q1 2019 Apr 12, 2019	BUY	$45.12 - $53.8 $13,536 - $16,140	300 Added 2.48%	12,400 $591,000
Q4 2018 Jan 15, 2019	SELL	$48.76 - $63.23 $4,876 - $6,323	-100 Reduced 0.82%	12,100 $629,000
Q3 2018 Oct 16, 2018	SELL	$55.19 - $62.25 $11,038 - $12,450	-200 Reduced 1.61%	12,200 $757,000
Q4 2017 Jan 16, 2018	SELL	$59.94 - $65.35 $8,991 - $9,802	-150 Reduced 1.2%	12,400 $760,000
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $693,136 - $799,937	12,550	12,550 $800,000

Others Institutions Holding BMY

# of Institutions

2,453

Shares Held

1.5B

Call Options Held

29.6M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $118B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Financial Corp with notifications on news.

Account

First Financial Corp Bristol Myers Squibb CO Transaction History